These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24898278)

  • 1. Chronic lymphedema in renal transplant recipients under immunosuppression with sirolimus: presentation of 2 cases.
    Baliu C; Esforzado N; Campistol JM; Mascaró JM
    JAMA Dermatol; 2014 Sep; 150(9):1023-4. PubMed ID: 24898278
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphedema associated with sirolimus in renal transplant recipients.
    Aboujaoude W; Milgrom ML; Govani MV
    Transplantation; 2004 Apr; 77(7):1094-6. PubMed ID: 15087777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sirolimus-induced lymphedema in a kidney-transplant recipient: Partial recovery after changeover to tacrolimus].
    Al Gain M; Crickx B; Bejar C; Chen L; Azeroual L; Marinho E; Descamps V
    Ann Dermatol Venereol; 2015 May; 142(5):350-5. PubMed ID: 25683011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-volume sirolimus-induced upper limb lymphedema after renal transplantation ipsilateral to the arteriovenous fistula.
    Vignes S; Brunet M; Blanchard M; Smail A; Arrault M
    Lymphat Res Biol; 2014 Sep; 12(3):185-8. PubMed ID: 25162929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe limb lymphedema in sirolimus-treated patients.
    Romagnoli J; Citterio F; Nanni G; Tondolo V; Castagneto M
    Transplant Proc; 2005 Mar; 37(2):834-6. PubMed ID: 15848548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus-associated lymphoedema: eight new cases and a proposed mechanism.
    Desai N; Heenan S; Mortimer PS
    Br J Dermatol; 2009 Jun; 160(6):1322-6. PubMed ID: 19302070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus: defining nephrotoxicity in the renal transplant recipient.
    Tomlanovich SJ; Vincenti F
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):198-9. PubMed ID: 17699406
    [No Abstract]   [Full Text] [Related]  

  • 8. One-sided limb lymphedema in a liver transplant recipient receiving sirolimus.
    van Onna M; Geerts A; Van Vlierberghe H; Berrevoet F; de Hemptinne B; Troisi R; Colle I
    Acta Gastroenterol Belg; 2007; 70(4):357-9. PubMed ID: 18330092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphedema of the Transplanted Kidney and Abdominal Wall with Ipsilateral Pleural Effusion Following Kidney Biopsy in a Patient Treated with Sirolimus: A Case Report and Review of the Literature.
    Rashid-Farokhi F; Afshar H
    Am J Case Rep; 2017 Dec; 18():1370-1376. PubMed ID: 29269724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized lymphedema in a sirolimus-treated renal transplant patient.
    De Bartolomeis C; Collini A; Rumberger B; Barni R; Ruggieri G; Bernini M; Carmellini M
    Clin Transplant; 2008; 22(2):254-7. PubMed ID: 18339149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chylous ascites in a renal transplant recipient under sirolimus (rapamycin) treatment.
    Castro G; Freitas C; Beirão I; Rocha G; Henriques AC; Cabrita A
    Transplant Proc; 2008 Jun; 40(5):1756-8. PubMed ID: 18589188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus-induced inflammatory lymphoedema of the breast resolved after switching to cyclosporine.
    Tauveron V; Bourdu S; Barbet C; de Muret A; Burgot M; Desmidt F; Vaillant L; Machet L
    Acta Derm Venereol; 2015 Jan; 95(1):108-9. PubMed ID: 24807192
    [No Abstract]   [Full Text] [Related]  

  • 13. Pregnancy under everolimus-based immunosuppression.
    Veroux M; Corona D; Veroux P
    Transpl Int; 2011 Dec; 24(12):e115-7. PubMed ID: 21950359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Immunosuppressive Therapy on the Occurrence of Atypical Hemolytic Uremic Syndrome in Renal Transplant Recipients.
    Raina R; Chauvin A; Fox K; Kesav N; Ascha M; Vachharajani TJ; Krishnappa V
    Ann Transplant; 2018 Sep; 23():631-638. PubMed ID: 30190449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation].
    Caletti C; Granata S; Tomei P; Lupo A; Zaza G
    G Ital Nefrol; 2014; 31(4):. PubMed ID: 25098457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphedema: an unusual complication of sirolimus therapy.
    Al-Otaibi T; Ahamed N; Nampoory MR; Al-Kandari N; Nair P; Hallm MA; Said T; Samhan M; Al-Mousawi M
    Transplant Proc; 2007 May; 39(4):1207-10. PubMed ID: 17524934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphedema in patients treated with sirolimus: 15 cases].
    Fourgeaud C; Simon L; Benoughidane B; Vignes S
    Rev Med Interne; 2019 Mar; 40(3):151-157. PubMed ID: 29752013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients.
    Hakeam HA; Al-Jedai AH; Raza SM; Hamawi K
    Ann Transplant; 2008; 13(2):46-53. PubMed ID: 18566560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients.
    Dansirikul C; Duffull SB; Morris RG; Tett SE
    Br J Clin Pharmacol; 2005 Nov; 60(5):560-5. PubMed ID: 16236047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of cancer and potential role of sirolimus immunosuppression conversion on mortality among a single-center renal transplantation cohort of 1,816 patients.
    Branco F; Cavadas V; Osório L; Carvalho F; Martins L; Dias L; Castro-Henriques A; Lima E
    Transplant Proc; 2011; 43(1):137-41. PubMed ID: 21335171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.